Processing your request

please wait...

Case Page


Case Status:    DISMISSED    
On or around 05/15/2020 (Notice of voluntarily dismissal)

Filing Date: September 24, 2019

According to the Complaint, Cambrex Corporation is the leading small molecule company that provides drug substance, drug product, and analytical services across the entire drug lifecycle.

This action stems from a proposed transaction announced on August 7, 2019, pursuant to which Cambrex will be acquired by Catalog Intermediate Inc. and Catalog Merger Sub Inc., which are controlled by investment funds advised by Permira Advisers LLC.

On August 7, 2019, Cambrex’s Board of Directors caused the Company to enter into an agreement and plan of merger with Permira. Pursuant to the terms of the Merger Agreement, Cambrex’s stockholders will receive $60.00 in cash for each share of Cambrex common stock they own.

On September 23, 2019, Defendants filed a proxy statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction, which scheduled a stockholder vote on the Proposed Transaction for October 23, 2019. The Complaint alleges that the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.

This case was voluntarily dismissed on May 15, 2020.


Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States


Ticker Symbol: CBM
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 19-CV-01793
JUDGE: Hon. Colm F. Connolly
DATE FILED: 09/24/2019
CLASS PERIOD END: 09/24/2019
  1. Rigrodsky & Long, P.A. (Wilmington)
  2. RM Law, P.C. (Berwyn)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available